Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3113 results found
Expand All
Apply All
3113 results found

BIO to file amicus brief in FTC merger case
Share
Good Day BIO Newsletter  •  August 24, 2023
BIO will file an amicus brief today in the Amgen-Horizon Federal Trade Commission (FTC) case—we have the scoop, plus what immunocompromised patients need to know about the benefits of COVID vaccines. (541 words, 2 minutes, 42 seconds)
Read More

$1.4 billion for COVID technology
Share
Good Day BIO Newsletter  •  August 23, 2023
The federal government awarded $1.4 billion in grants to accelerate new COVID-19 technologies as new variants are causing concern—plus, as heat records become the “new normal,” what’s the role for biotech? (594 words, 2 minutes, 58 seconds)
Read More

FDA Ad Promo (Tactics)
Share
BIO Professional Development Courses  •  August 22, 2023
A comprehensive review of the Do's and Don'ts for AD/Promo Tactics: covers types of drug and medical device advertising (disease state/unbranded, product/branded, reminder, institutional, recruitment), promotional labeling (booklets, brochures, direct mail, exhibit booths, file cards, monographs, publications, sales aids, videos).
Read More

Another RSV victory
Share
Good Day BIO Newsletter  •  August 22, 2023
“The Year of RSV” continues with FDA’s third RSV approval, and a new report highlights the economic value of California’s life sciences sector.
Read More

BIO Federal Government Relations Committee Meeting
Share
August 21, 2023
The Federal Government Relations Committee concentrates on educating and lobbying government officials regarding legislative proposals affecting the biotechnology industry. The committee reviews the BIO legislative and regulatory agenda as a whole to set priorities and strategies; initiates BIO policy discussions regarding legislation; and provides advice and recommendations to the Board. Committee members meet with various government officials and their staffs to gain information, offer insight and advice, and buttress BIO positions. The committee collaborates on substance and formulates legislative strategy for major BIO priorities. For more information and to join the Committee, please contact Amanda Galich (agalich@bio.org).
Read More

What's happening in the states
Share
Good Day BIO Newsletter  •  August 21, 2023
Bio.News caught up with BIO’s State Government Affairs team for a mid-year state legislature update—here’s what you need to know, from Medicare to biofuels. (550 words, 2 minutes, 45 seconds)
Read More

How Medicare misinformation threatens access
Share
Good Day BIO Newsletter  •  August 18, 2023
Ending the week with how misinformation on Medicare costs threatens patients’ access to Alzheimer’s treatments, and what USTR and BIO are saying about Mexico’s corn ban. Plus, we have a special look at how BIO used new social sharing technology to drive engagement at the International Convention in June. (687 words, 3 minutes, 26 seconds)
Read More

Dispute Panel 'Important Next Step' to Return to Science-Based Trade with Mexico
Share
Press Release  •  August 17, 2023
The following statement may be attributed to Nancy Travis, vice president of international affairs, BIO. “The Biotechnology Innovation Organization supports today’s action by the Office of the U.S. Trade Representative to request formation of a dispute resolution panel under the U.S. – Mexico – Canada Agreement (USMCA) concerning Mexico’s harmful ban on biotech corn. We thank USTR for moving forward expeditiously with this important next step toward returning trade with Mexico to the science-based trade conditions to which North American trade partners agreed in the USMCA. “Today’s action is necessary to ensure food security for Mexico’s consumers and supports access to safe, sustainable agricultural technologies for North American farmers.”
Read More

Mifepristone and Mexico's corn ban
Share
Good Day BIO Newsletter  •  August 17, 2023
We interrupt your mid-August doldrums with big news: a federal appeals court rules to restrict access to mifepristone, and USTR is expected to take action today on Mexico’s corn ban. (579 words, 2 minutes, 53 seconds)
Read More

Vaccines have nearly eradicated polio
Share
Good Day BIO Newsletter  •  August 16, 2023
We’re close to eradicating wild poliovirus—but we need broad vaccination coverage to get there. Plus, Google announced a new program that uses blockchain and SAFs to reduce business travel emissions. (471 words, 2 minutes, 21 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 84
  • 85
  • 86
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO